News

U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO

3 Mins read

After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading, two of which qualified for inclusion in our stats, while one deal was pushed back (SHIM

2 IPOs During the Week of October 30th, 2023
Issuer Business DealS ize Market Cap at IPO Price vs. Midpoint First Day Return Return at 11/03
Alpha Technology Group (ATGL) $7M $60M -11% +10% +47%
Provides software development and other services in Hong Kong.
Lexeo Therapeutics (LXEO) $100M $282M -21% -9% -9%
Phase 1 biotech developing gene therapies for cardio and neuro diseases.

4 Filings During the Week of October 30th, 2023
Issuer Business DealSize Sector Lead Underwriter
Neo-Concept International (NCI) $9M Consumer Discretionary Revere Sec.
Hong Kong-based apparel retailer and supply chain services provider.
Ten-League International (TLIH) $32M Industrials Eddid Securities
Singapore-based provider of heavy equipment and engineering consultancy services.
Baiya International (BIYA) $15M Industrials Revere Sec.
Chinese HR platform that connects companies and blue-collar staffing agencies.
BloomZ (BLMZ) $17M Communication Services Network 1
Japanese audio production and voice actor management company.

U.S. IPO Calendar
Issuer Business Deal Size Market Cap Price Range Shares Filed Top Bookrunners
Hamilton Group (HG) Hamilton, Bermuda $255M$1,923M $16 – $1815,000,000 BarclaysMorgan Stanley
Bermuda-based provider of reinsurance and specialty insurance.
Shimmick (SHIM) Irvine, CA $50M$333M $10 – $124,550,000 Roth Cap.
California-based construction firm specializing in public water infrastructure.

Read the full article here

Related posts
News

Yearly Portfolio Review - November Dividend Income Report

1 Mins read
This article was written by Follow My name is Mike and I’m the author of The Dividend Guy Blog & The Dividend…
News

Lucid Group Stock: Not Right EV Stock To Bank On, Not Fit For Mass Market (NASDAQ:LCID)

1 Mins read
This article was written by Follow With combined experience of covering technology companies on Wall Street and working in Silicon Valley, and…
News

Morgan Stanley: Some Of The Preferred Shares Still Yield 7% (NYSE:MS)

1 Mins read
This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon….
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *